Sleep Apnea Devices Market Outlook To 2024: Key Product Categories (Airway Clearance Systems, Adaptive Servo-Ventilation Devices, Positive Airway Pressure Devices, Oral Appliances, Oxygen Devices, Actigraphy Systems, PSG Devices, Respiratory Polygraphs, Pulse Oximeters), Regional Segmentation, Competitive Dynamics, M&A Insights, Segment Forecast and Conclusion

$3,650.00$6,650.00

Clear
  • Report Description
  • Table of Content
  • Highlight
  • Research Methodology
  • Request Free Sample

The global sleep apnea devices market was valued at $4.8bn in 2016 and is anticipated to reach $8.1bn by 2024.

 

The sleep apnea devices market is expected to grow with a lucrative CAGR of 7.9% over the forecast period, owing to factors such as growing aging population, increasing the prevalence of respiratory and sleep disorders, lifestyle factors such as smoking, substance abuse, and environmental pollution. Sleep apnea is a highly prevalent condition across different age groups however, most of the people are not aware of their condition. Due to this condition, the breathing pattern is distorted due to the lack of oxygen supply during sleep and is associated with snoring and restlessness due to increased airway resistance.

 

The population which is at an increased risk of suffering from sleep disorders include male candidates who are obese, suffer from hypertension, who use alcohol and sedatives regularly, are prone to smoking, have a family history of OSA and people who suffer from endocrine and metabolic disorders. The different types of sleep apnea include complex sleep apnea, obstructive sleep apnea (OSA), central sleep apnea (CSA). The OSA is the most commonly identified type of condition, which can be treated using sleep masks and positive airway pressure (PAP) devices.

 

Sleep Apnea Devices Market 2024

 

The U.S. market accounts for the largest revenue share, owing to high disease burden, growing awareness pertaining to various sleep disorders and availability of well-developed healthcare infrastructure and reimbursement framework. The American Sleep Apnea Association estimates that over 22 million people suffer from sleep apnea, where nearly 80% cases are related to OSA. The untreated OSA can lead to a spike in blood pressure, chronic heart failure, stroke and several other co-morbidities. Moreover, obesity and diabetes are amongst the major conditions driving the sleep apnea devices market over the next few years.

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Products”

 

Estimated Average sleep apnea devices cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

The products available in the market are available at different price points based on their therapeutic or diagnostic application. For instance, the sleep apnea masks are available in the range of USD 5 to USD 150 and above and the PAP devices such as A-PAP, Bi-PAP and C-PAP are available in the range of USD 400 to USD 800 and above based on the technology, product size, portability and battery life.

 

Sleep Apnea Devices Market by “Product”

 

The market is broadly categorized based on therapeutic and diagnostic applications. The therapeutic category includes products such as airway clearance systems, PAP devices, oral devices, oxygen devices, adaptive servo-ventilation systems and others. The diagnostic category includes products such as actigraphy systems, PSG devices, respiratory polygraphs and pulse oximeters.

 

In 2015, the PAP devices accounted for over 43% the market share and are expected to extend their dominance over the forecast period. The majority of OSA patients are provided treatment using these PAP devices, and growing prevalence of OSA and CSA are expected to reinforce growth over the forecast period.  The oral appliances are expected to outperform other categories with a CAGR of 11% over the forecast period, due to rising demand for dental sleep apnea therapies.

 

Regional Segmentation

 

In 2016, North America accounted for a dominant share of over 37.5% due to the high disease burden and growing awareness about sleep apnea and associated co-morbidities. The U.S. region contributes the bulk of the revenue due to higher patient volume, treatment rate and availability of reimbursement. Moreover, the presence of sleep diagnostic centers and collaboration, growing demand for dental sleep apnea appliances in the region are expected to positively reinforce growth over the forecast period.

 

By 2024, Asia-Pacific is expected to emerge as the fastest growing region with a CAGR of 8.7%. The high growth is anticipated because of rising prevalence of obesity, diabetes, and hypertension in the region. Moreover, increase in air pollution, growing consumption of tobacco and alcohol, and highly stressful lifestyle are expected to drive the prevalence of sleep disorders. For instance, countries such as India and China now have the highest number of obese and diabetic population. Moreover, rising awareness and introduction of several low-cost products to cater to the growing needs of the region are expected to reinforce demand over the forecast period.

 

Merger and Acquisition Landscape

 

The sleep disorders landscape is witnessing increasing interest for merger and acquisition activities. The companies are driven by a growing urge to use forward and backward integration strategies to minimize the supply side and demand side risks and consolidate their market dominance. Moreover, the players are actively seeking M&A opportunities to exploit the high growing markets of Asia Pacific region. The drive to expand the global footprint and continuously expand product portfolio is encouraging more companies to venture into M&A activity. For instance, in 2016, SleepWorks and MedBridge Home Medical acquired the CPAP division of Active Healthcare (IntegraSleep). The merged entity is operated as the Sound Sleep Institute, with presence across the U.S. region.

 

Top Players & Company Share

 

The key market participants include ResMed, Invacare Corporation, ImThera Medical Inc, Fisher & Paykel Healthcare, Phillips Respironics, Curative Medical Inc., BMC Medical Co.Ltd, GE Healthcare, Braebon Medical Corporation, Cadwell Laboratories and Becton, Dickinson and Company. The top 4 players such as ResMed, Becton, Dickinson and Company, Phillips Respironics, and Fisher & Paykel Healthcare account for over 90% the market due to the presence of wide product portfolio with reimbursement coverage, high investment in R&D and strong network of distributors and partners, thus creating a difficult environment for new players to sustain and compete in the market.

 

Market Segmentation

 

Sleep Apnea Devices Market by Product (Revenue, Million, 2014 – 2024)

  • Diagnostic Devices
  • Actigraphy Systems
  • Polysomnography (PSG) Devices
  • Respiratory Polygraph
  • Single Channel Screening Devices (Pulse Oximeters)
  • Therapeutic Devices
  • Adaptive Servo Ventilation (ASV) Systems
  • Airway Clearance System
  • Positive Airway Pressure (PAP) Devices
  • Oral Appliances
  • Oxygen Devices

Sleep Apnea Devices Market Regional Outlook (Revenue, USD Million, 20124- 2024)

 

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Asia Pacific
  • Japan
  • China
  • India

Latin America

  • Brazil
  • Mexico
  • Columbia

Middle East and Africa

  • South Africa
  • Saudi Arabia

Chapter 1 Methodology and Scope

  • Research Methodology
  • Research Scope & Assumptions
  • List of Data Sources

Chapter 2 Executive Summary

Chapter 3 Sleep Apnea Devices Market Overview

  • Global R&D Expenditure
  • Global Healthcare Expenditure

Chapter 4 Sleep Apnea Devices Market Industry Outlook

  • Market Segmentation
  • Market Size and Growth Prospects
  • Leading Brand Dynamics
  • Key Market Drivers
    • Rising Prevalence of Sleep Disorders
    • Increasing Geriatric Population
    • Growing Investment for Research and Development
  • Key Market Challenges
    • Lack of Awareness About Sleep Disorders
    • Shortage of Sleep Diagnostic Centers
  • Key Opportunities Prioritized
  • Industry Analysis - Porter’s
  • Sleep Apnea Devices Market-PESTEL Analysis

Chapter 5: - Sleep Apnea Devices Market by “Product” (USD Million)

Sleep Apnea Devices Market Landscape by Product Type- 2016 & 2024
  • Sleep Apnea Therapeutic Products
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Airway Clearance Systems
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Adaptive Servo-Ventilation Systems
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Positive Airway Pressure (PAP) Systems
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Oral Appliances
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Oxygen Devices
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Others
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Diagnostic devices
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Actigraphy Systems
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Polysomnography (PSG) Devices
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Respiratory Polygraphs
    • Market Landscape Analysis, 2016-2024 (USD Mn)
  • Pulse oximeters
    • Market Landscape Analysis, 2016-2024 (USD Mn)

Chapter 6: - Regional Market Outlook

Sleep Apnea Devices Market Landscape by Region- 2016
  • North America Market Landscape Analysis, 2016-2024 (USD Mn)
    • U.S. Market Landscape Analysis, 2016-2024
    • Canada Market Landscape Analysis-2016-2024
  • Europe Market Landscape Analysis, 2016-2024 (USD Mn)
    • UK Market Landscape Analysis, 2016-2024
    • Germany Market Landscape Analysis, 2016-2024
    • France Market Landscape Analysis, 2016-2024
    • Italy Market Landscape Analysis, 2016-2024
    • Spain Market Landscape Analysis, 2016-2024
  • Latin America Market Landscape Analysis, 2016-2024 (USD Mn)
    • Brazil Market Landscape Analysis, 2016-2024
    • Mexico Market Landscape Analysis, 2016-2024
    • Colombia Market Landscape Analysis, 2016-2024
  • Asia pacific Market Landscape Analysis, 2016-2024 (USD Mn)
    • Japan Market Landscape Analysis, 2016-2024
    • China Market Landscape Analysis, 2016-2024
    • India Market Landscape Analysis, 2016-2024
  • Middle East & Africa Market Landscape Analysis, 2014-2024 (USD Mn)
    • Saudi Arabia Market Landscape Analysis, 2014-2024
    • South Africa Market Landscape Analysis, 2014-2024
 

Chapter 7: Pricing Analysis

  Optimal Price Points (OPP), Indifference price points (IPP) and Range of Acceptable Prices and (RAP) of leading brands by Region- 2016
  • North America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • U.S. Pricing Analysis-2016
    • Canada Pricing Analysis-2016
  • Europe Pricing Analysis (OPP, IPP, and RAP - 2016)
    • UK Pricing Analysis-2016
    • Germany Pricing Analysis-2016
    • France Pricing Analysis-2016
    • Italy Pricing Analysis-2016
    • Spain Pricing Analysis-2016
  • Latin America Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Brazil Pricing Analysis-2016
    • Mexico Pricing Analysis-2016
    • Colombia Pricing Analysis-2016
  • Asia Pacific Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Japan Pricing Analysis-2016
    • China Pricing Analysis-2016
    • India Pricing Analysis-2016
  • Middle East Pricing Analysis (OPP, IPP, and RAP - 2016)
    • Saudi Arabia Pricing Analysis-2016
    • South Africa Pricing Analysis-2016

Chapter 8: Sleep Apnea Devices Pipeline Analysis

  • Executive Summary
  • Late Stage Pipeline Analysis
  • Key R&D Trends

Chapter 9: Sleep Apnea Devices Merger &Acquisition Outlook

  • Factors driving M&A in sleep apnea devices market
  • Key trends and future outlook

Chapter 10: Sleep Apnea Devices Regulatory & Patent Outlook

  • Regulatory Landscape by Region (U.S., Europe, and RoW)
  • Patent Landscape by Region (U.S., Europe, and RoW)

Chapter 11: Competitive Landscape

  • BMC Medical Co. Ltd.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Braebon Medical Corporation
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • ImThera Medical Inc.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Invacare Corporation
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Cadwell Laboratories Inc.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Curative Medical Inc.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Fisher & Paykel Healthcare
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • GE Healthcare
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Compumedics Limited
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Curative Medical Inc.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Natus Medical Inc.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • Philips Respironics
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  • ResMed Inc.
    • Company Overview
    • Financial Performance
    • Product Pipeline
    • Strategic Initiative
  List of Tables  
  • TABLE 1 Sleep Apnea Devices Market - Industry Snapshot & Key Buying Criteria, 2014 - 2024
  • TABLE 2 Global Sleep Apnea Devices Market, 2014 – 2024
  • TABLE 3 Global Sleep Apnea Devices Market Analysis by Product-2016
  • TABLE 4 Global Sleep Apnea Devices Market Analysis by Technology -2016
  • TABLE 5 Global Sleep Apnea Devices Market Analysis by Application-2016
  • TABLE 7 Global Sleep Apnea Devices Market Analysis by Geography-2016
  • TABLE 8 Global Sleep Apnea Devices Market Analysis by Leading Brands-2016
  • TABLE 9 Sleep Apnea Devices Market - Key market driver analysis
  • TABLE 10 Sleep Apnea Devices Market - Key market restraint analysis
  • TABLE 11 North America Market Sleep Apnea Devices Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 12U.S. Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 13 Canada Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 14 Europe Sleep Apnea Devices Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 15 U.K Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 16 Germany Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 17 France Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 18 Italy Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 19 Spain Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 20 Latin America Sleep Apnea Devices Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 21 Brazil Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 22 Mexico Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 20 Colombia Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 21 Asia pacific Sleep Apnea Devices Market Landscape Analysis, 2016-2024 (USD Mn)
  • TABLE 22 Japan Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 23 China Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 24 India Sleep Apnea Devices Market Landscape Analysis, 2016-2024
  • TABLE 25 North America Pricing Analysis
  • TABLE 26 North America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 27 U.S. Pricing Analysis-2016
  • TABLE 28 Canada Pricing Analysis-2016
  • TABLE 29 Europe Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 30 U.K Pricing Analysis-2016
  • TABLE 31 Germany Pricing Analysis-2016
  • TABLE 32 France Pricing Analysis-2016
  • TABLE 33 Italy Pricing Analysis-2016
  • TABLE 34 Spain Pricing Analysis-2016
  • TABLE 35 Latin America Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 36 Brazil Pricing Analysis-2016
  • TABLE 37 Mexico Pricing Analysis-2016
  • TABLE 38 Colombia Pricing Analysis-2016
  • TABLE 39 Asia Pacific Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 40 Japan Pricing Analysis-2016
  • TABLE 41 China Pricing Analysis-2016
  • TABLE 42 India Pricing Analysis-2016
  • TABLE 43 Middle East Pricing Analysis (OPP, IPP, and RAP- 2016)
  • TABLE 44 Saudi Arabia Pricing Analysis-2016
  • TABLE 45 South Africa Pricing Analysis-2016
  List of Figures  
  • 1 Sleep Apnea Devices Market Segmentation
  • 2 Market Size & Growth Prospects
  • 3 Leading Brand Dynamics
  • 4 Penetration & Growth Prospects
  • 5 Industry Analysis – Porter’s
  • 6 Sleep Apnea Devices Market – PESTEL Analysis
  • 7 Sleep Apnea Devices Market Share by Product Type, 2016 & 2024
  • 8 Sleep Apnea Devices Market Share by Technology Type, 2016 & 2024
  • 9 Sleep Apnea Devices Market Share by Application Type, 2016 & 2024
  • 10 Sleep Apnea Devices Market Share by Region, 2016 & 2024

Key Insights Addressed:  

  • Defining market size from 2014 to 2016.
  • Estimating market growth till 2024 and consequence market forecast.
  • Identifying market drivers, restraints & future opportunities and allowing decision-maker with a range of possible outcomes and the probabilities that will occur for any choice of action.
  • Market segments and regions that will drive or lead market growth.
  • Defining Optimal Price Point (OPP) which will be accepted and recommended by maximum customers.
  • A bird’s-eye view of the competitive landscape and the key market players.
  • Key strategic growth driver adopted by market players. In-depth analysis of their strategies and implication on competition & growth.
    Key Findings:    
  • The global sleep apnea devices market was valued at $4.8bn in 2016 and is anticipated to reach $8.1bn by 2024.
  • The sleep apnea devices market is expected to grow with a lucrative CAGR of 7.9% over the forecast period, owing to factors such as growing aging population, increasing the prevalence of respiratory and sleep disorders, lifestyle factors such as smoking, substance abuse, and environmental pollution.
  • The different types of sleep apnea include complex sleep apnea, obstructive sleep apnea (OSA), central sleep apnea (CSA).
  • In 2015, the PAP devices accounted for over 43% the market share and are expected to extend their dominance over the forecast period.
  • The key market participants include ResMed, Invacare Corporation, ImThera Medical Inc, Fisher & Paykel Healthcare, Phillips Respironics, Curative Medical Inc., BMC Medical Co.Ltd, GE Healthcare, Braebon Medical Corporation, Cadwell Laboratories and Becton, Dickinson and Company.

Ameri Research implies a unique methodology of published information and primary research to bring key insights to customer decision making process. Our analytics model helps us to understand the structured and unstructured information from various sources. Key steps involves in the process are as below-

  1. Analyzing Published Information- Access to large pool of paid and unpaid published information via different sources and analyzing market trend.
  2. Setting Foundation- Input from analysis of secondary sources set our foundation to market analysis and helps in setting the scope for further research. Setting the scope involves Ameri Research proprietary statistical model, discussion with industry leaders, internal brainstorming, key discussion pointers from various forums etc.
  3. Need Gap Analysis- Defining the gap between our scope and availability of information.
  4. KOL Panel Discussion- Focused Group Discussion with a structured discussion guide to fine tune the gap and deriving the factors driving/restraining the market trend.
  5. Quantitative Research- Sampling large number of industry players, Education/Research Institutes, Government bodies, NGOs, Individual acclaimed researchers and conducting the primary interview with a structured questionnaire.
  6. Data Triangulation- We apply bottom-up demand approach or top-down estimation or a combined approach to triangulate the data points.
  7. Analyst Comment- Each of our analysts carries large pool of experience from domain perspective and add their value which is directional in nature
global-aesthetic-dermatology-market

To request a free sample copy of this report, please complete the form below verified and secure

We offer complete free customization that addresses client’s need. This includes insights from primary market research and a 60-minute free analyst consultation post report purchase.

This website is secure and your personal details are safe. Privacy policy

Description

The global sleep apnea devices market was valued at $4.8bn in 2016 and is anticipated to reach $8.1bn by 2024.

 

The sleep apnea devices market is expected to grow with a lucrative CAGR of 7.9% over the forecast period, owing to factors such as growing aging population, increasing the prevalence of respiratory and sleep disorders, lifestyle factors such as smoking, substance abuse, and environmental pollution. Sleep apnea is a highly prevalent condition across different age groups however, most of the people are not aware of their condition. Due to this condition, the breathing pattern is distorted due to the lack of oxygen supply during sleep and is associated with snoring and restlessness due to increased airway resistance.

 

The population which is at an increased risk of suffering from sleep disorders include male candidates who are obese, suffer from hypertension, who use alcohol and sedatives regularly, are prone to smoking, have a family history of OSA and people who suffer from endocrine and metabolic disorders. The different types of sleep apnea include complex sleep apnea, obstructive sleep apnea (OSA), central sleep apnea (CSA). The OSA is the most commonly identified type of condition, which can be treated using sleep masks and positive airway pressure (PAP) devices.

 

Sleep Apnea Devices Market 2024

 

The U.S. market accounts for the largest revenue share, owing to high disease burden, growing awareness pertaining to various sleep disorders and availability of well-developed healthcare infrastructure and reimbursement framework. The American Sleep Apnea Association estimates that over 22 million people suffer from sleep apnea, where nearly 80% cases are related to OSA. The untreated OSA can lead to a spike in blood pressure, chronic heart failure, stroke and several other co-morbidities. Moreover, obesity and diabetes are amongst the major conditions driving the sleep apnea devices market over the next few years.

 

Pricing Analysis

 

“Optimal Price Point (OPP) for Products”

 

Estimated Average sleep apnea devices cost – $ xx globally. However, with improving access and availability of options, OPP and range of acceptable Prices (RAP) are going to change. We at Ameri Research continuously track these prices with our proprietary pricing model.

 

The products available in the market are available at different price points based on their therapeutic or diagnostic application. For instance, the sleep apnea masks are available in the range of USD 5 to USD 150 and above and the PAP devices such as A-PAP, Bi-PAP and C-PAP are available in the range of USD 400 to USD 800 and above based on the technology, product size, portability and battery life.

 

Sleep Apnea Devices Market by “Product”

 

The market is broadly categorized based on therapeutic and diagnostic applications. The therapeutic category includes products such as airway clearance systems, PAP devices, oral devices, oxygen devices, adaptive servo-ventilation systems and others. The diagnostic category includes products such as actigraphy systems, PSG devices, respiratory polygraphs and pulse oximeters.

 

In 2015, the PAP devices accounted for over 43% the market share and are expected to extend their dominance over the forecast period. The majority of OSA patients are provided treatment using these PAP devices, and growing prevalence of OSA and CSA are expected to reinforce growth over the forecast period.  The oral appliances are expected to outperform other categories with a CAGR of 11% over the forecast period, due to rising demand for dental sleep apnea therapies.

 

Regional Segmentation

 

In 2016, North America accounted for a dominant share of over 37.5% due to the high disease burden and growing awareness about sleep apnea and associated co-morbidities. The U.S. region contributes the bulk of the revenue due to higher patient volume, treatment rate and availability of reimbursement. Moreover, the presence of sleep diagnostic centers and collaboration, growing demand for dental sleep apnea appliances in the region are expected to positively reinforce growth over the forecast period.

 

By 2024, Asia-Pacific is expected to emerge as the fastest growing region with a CAGR of 8.7%. The high growth is anticipated because of rising prevalence of obesity, diabetes, and hypertension in the region. Moreover, increase in air pollution, growing consumption of tobacco and alcohol, and highly stressful lifestyle are expected to drive the prevalence of sleep disorders. For instance, countries such as India and China now have the highest number of obese and diabetic population. Moreover, rising awareness and introduction of several low-cost products to cater to the growing needs of the region are expected to reinforce demand over the forecast period.

 

Merger and Acquisition Landscape

 

The sleep disorders landscape is witnessing increasing interest for merger and acquisition activities. The companies are driven by a growing urge to use forward and backward integration strategies to minimize the supply side and demand side risks and consolidate their market dominance. Moreover, the players are actively seeking M&A opportunities to exploit the high growing markets of Asia Pacific region. The drive to expand the global footprint and continuously expand product portfolio is encouraging more companies to venture into M&A activity. For instance, in 2016, SleepWorks and MedBridge Home Medical acquired the CPAP division of Active Healthcare (IntegraSleep). The merged entity is operated as the Sound Sleep Institute, with presence across the U.S. region.

 

Top Players & Company Share

 

The key market participants include ResMed, Invacare Corporation, ImThera Medical Inc, Fisher & Paykel Healthcare, Phillips Respironics, Curative Medical Inc., BMC Medical Co.Ltd, GE Healthcare, Braebon Medical Corporation, Cadwell Laboratories and Becton, Dickinson and Company. The top 4 players such as ResMed, Becton, Dickinson and Company, Phillips Respironics, and Fisher & Paykel Healthcare account for over 90% the market due to the presence of wide product portfolio with reimbursement coverage, high investment in R&D and strong network of distributors and partners, thus creating a difficult environment for new players to sustain and compete in the market.

 

Market Segmentation

 

Sleep Apnea Devices Market by Product (Revenue, Million, 2014 – 2024)

  • Diagnostic Devices
  • Actigraphy Systems
  • Polysomnography (PSG) Devices
  • Respiratory Polygraph
  • Single Channel Screening Devices (Pulse Oximeters)
  • Therapeutic Devices
  • Adaptive Servo Ventilation (ASV) Systems
  • Airway Clearance System
  • Positive Airway Pressure (PAP) Devices
  • Oral Appliances
  • Oxygen Devices

Sleep Apnea Devices Market Regional Outlook (Revenue, USD Million, 20124- 2024)

 

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Asia Pacific
  • Japan
  • China
  • India

Latin America

  • Brazil
  • Mexico
  • Columbia

Middle East and Africa

  • South Africa
  • Saudi Arabia

Additional information

Price

Single User $3,650, Multiple User $4,650, Enterprise User $6,650